The impact of muscarinic or mGlu activators on some NO-dependent biochemical pathways in MK-801 animal model

Grzegorz Burnat(Maj Institute of Pharmacology), Joanna M. Wierońska(Maj Institute of Pharmacology)

Research Square

April 2, 2025

10.21203/rs.3.rs-6287635/v1

Cited by 0

Related Papers

mGlu4R, mGlu7R, and mGlu8R allosteric modulation for treating acute and chronic neurodegenerative disorders

|Pharmacological Reports|2024|3

The impact of muscarinic and mGlu receptors modulators on MK-801-induced impairments in NO-dependent processes both in vitro and in vivo

|Pharmacological Reports|2025|0